Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants

Clinical trial NCT01923311 · TERMINATED

Trial details

NCT number: NCT01923311
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acquired Immune Deficiency Syndrome (AIDS)HIV Infections

Start date: 2013-08-26
Primary completion: 2017-11-03
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.